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T cell microvilli constitute immunological
synaptosomes that carry messages to
antigen-presenting cells
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Microvilli on T cells have been proposed to survey surfaces of antigen-presenting cells (APC)
or facilitate adhesion under ﬂow; however, whether they serve essential functions during T
cell activation remains unclear. Here we show that antigen-speciﬁc T cells deposit membrane
particles derived from microvilli onto the surface of cognate antigen-bearing APCs. Microvilli
carry T cell receptors (TCR) at all stages of T cell activation and are released as large TCR-
enriched, T cell microvilli particles (TMP) in a process of trogocytosis. These microvilli
exclusively contain protein arrestin-domain-containing protein 1, which is directly involved in
membrane budding and, in combination with vacuolar protein-sorting-associated protein 4,
transforms large TMPs into smaller, exosome-sized TMPs. Notably, TMPs from CD4+ T cells
are enriched with LFA-2/CD2 and various cytokines involved in activating dendritic cells.
Collectively, these results demonstrate that T cell microvilli constitute “immunological
synaptosomes” that carry T cell messages to APCs.
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An extensive body of evidence indicates that surface pro-teins are commonly transferred between immune cellsin vitro and in vivo, and it is clear that this phenomenon
is widespread. With characteristics distinct from enzymatic
cleavage or exosome-mediated transfer, such cell-surface protein
transfer has been referred to by different investigators as
“absorption”1, “internalization”2, or “trogocytosis”3,4 (from the
Greek “trogo”, meaning to gnaw or nibble). In general, the process
of trogocytosis is antigen-dependent5, with one of the best-known
examples being the transfer of peptide-major histocompatibility
complexes (MHCs) from antigen-presenting cells (APCs) to
T cells2,6. Bidirectional trogocytosis has also been described, in
which mouse APCs acquire the T cell receptor (TCR), and the
counterpart T cells acquire peptide-bound MHCs7; however, the
molecular mechanism underlying the process of trogocytosis
remains unclear. Proposed mechanisms include endocytosis of
the two synaptic membranes or an enclosed membrane being
“torn off” as cells part.
As a separate ﬁeld of study from trogocytosis, “direct vesicle
budding” from the plasma membrane has been demonstrated,
with the resulting vesicles termed microparticles, shedding vesi-
cles, ectosomes, or arrestin-domain-containing protein-1
(Arrdc1)-mediated microvesicles4. Unlike trogocytosis, direct
vesicle budding requires enzymes, including the ATPase vacuolar
protein-sorting-associated protein 4 (Vps4) and the endosomal-
sorting complex required for transport-1 component tumor-
susceptibility gene 101 (TSG101)8,9. Arrdc1 is exclusively loca-
lized to the plasma membrane and mediates microvesicle budding
directly from the plasma membrane by co-opting Vps4 and
TSG1018,9. Consistent with this ﬁnding, a recent report demon-
strated that TSG101 sorts TCRs into the immunological synapse
(IS) center, and thereafter Vps4 mediates membrane budding of
the TCR-enriched microvesicles10. However, the report was
unclear regarding the exact location in the plasma membrane
from which the microvesicles budded10.
Lymphocytes contain abundant ﬂexible projections termed
microvilli, the inside of which contain many parallel bundles of
actin ﬁlaments that extend the cell membrane in the form of a
ﬁnger. Previous reports demonstrated microvilli involvement
during the initial rolling phase of extravasation via segregation of
two lymphocyte receptors, L-selectin, and α4β7 integrin on the tip
of the microvilli, which is critical for lymphocyte attachment and
rolling under physiologic ﬂow11. Since then, the biological role of
microvilli has remained surprisingly unrecognized. However, a
recent super-resolution microscopy approach demonstrated that
TCRs are highly clustered on the tips of microvilli, immediately
highlighting these surface projections as effective sensors for
antigenic moieties on APCs or target cells12. Shortly thereafter,
the mechanism of how microvilli on T cells search opposing cells
and surfaces before and during antigen recognition was descri-
bed13. However, in addition to their key role in antigen sensing
on APCs, whether they serve essential functions during T cell
activation remains largely unclear.
In this study, we observe that single T cell contacts with APCs
occur through microvillar extensions, which appear to serve as
locations for sequestration of immunologically important mole-
cules, including TCR complexes, costimulatory and adhesion
molecules, and various cytokines. We ﬁnd that microvilli are
separated from the T cell body by the combined action of two
independent mechanisms (trogocytosis and membrane budding)
and are deposited at the surface of cognate APCs, thereby
potentially acting as an effective means of delivering T cell
messages to cognate APCs. Consistent with this potential role,
these T cell microvilli-derived particles (TMP) are independently
capable of activating cognate dendritic cells (DC). Therefore, our
ﬁndings suggest that T cell microvilli might serve as
“immunological synaptosomes” with TMPs as a class of mem-
brane vesicles serving as conveyors of T cell messages or traits to
cognate APCs.
Results
T cells generate microvilli particles upon TCR stimulation. As
shown in Fig. 1a (panel i), T cells contain abundant ﬁnger-like
microvilli on their surface, although their roles and destinies are
unclear. At the very early stage of IS formation, microvilli are
polarized toward the surface of antigen-bearing APCs (Fig. 1a,
panel ii; ~5 min), presumably to scan and sense the antigens on
APCs12,13,15. Similarly, when naive T cells are placed on anti-CD3
antibody-coated coverglass, these microvilli extend to the
antibody-coated surface (Fig. 1b, early). However, the microvilli
mostly disappear as the IS matures (Fig. 1b, panel ii; ~30 min;
mature), during which large-scale actin rearrangement occurs in
the distal supramolecular activation cluster (dSMAC) of the IS16.
This phenomenon might have impeded recognition of the
importance of microvilli in the activation process of T cells. We
noticed that some microvilli remain on the outermost edge of
mature T cells and are more evident at the late stage (Fig. 1b,
mature and late). Strikingly, many rod-shaped microvilli were
separated from the T cell body and spread on the antibody-coated
surface during the terminal stage (Fig. 1b, terminal). Microvilli
separation is not an artefact, as this phenomenon also occurs on
planar lipid bilayers presenting peptide-MHC and intercellular
adhesion molecule-1 (ICAM-1) (Fig. 1c). Transmission electron
microscopy (TEM) showed that separated microvilli were irre-
gular in size, with some comparable to that of mitochondria
(Fig. 1d). We named these particles TMPs (Fig. 1d).
Because EM analysis is limited in its ability to represent microvilli
dynamics during IS formation and dissociation, we developed a
ﬂuorescence-based method to trace microvilli movement under live
conditions. To that end, we selected tetraspanin protein 25
(TSPAN25)17 and a single transmembrane protein V-set and
transmembrane-domain-containing 5 (Vstm5)18. Both proteins
were previously identiﬁed as localizing at membrane-protrusive
regions, especially in microvilli or ﬁlopodia17,18. We observed that
TSPAN25 was highly expressed in T cells, and that green
ﬂuorescent protein (GFP)-fused TSPAN25 (TS25G) overlapped
with cortical F-actin in T cells (Supplementary Figs. 1a and b).
However, TSPAN25 overexpression increased the number and
length of microvilli in 293 T cells (Supplementary Fig. 1b), as well as
the thickness of microvilli in Jurkat T cells (Supplementary Fig. 1c).
By contrast, although Vstm5 was expressed at relatively low levels in
T cells, GFP-fused Vstm5 (V5G) minimally affected microvilli
length as compared with TSPAN25 (Supplementary Fig. 1b and c).
Additionally, both wild type and V5G were recovered in the
membrane fraction and not cleaved by Endo H (Supplementary
Fig. 1d), suggesting that Vstm5 is a membrane protein. Never-
theless, in contrast to molecules that were only segregated at the tip
of microvilli, such as TCRβ and ζ-chain in this study, Vstm5
displayed no preferential clustering at the tip of microvilli, but
rather was distributed throughout the entire stalk region of
microvilli, expressed at low levels in the inner area of cells (Fig. 2a),
and signiﬁcantly co-localized with cortical F-actin (Fig. 2b). Vstm5
contained a potential palmitoylation motif (CXXC) at the end of its
transmembrane sequence18, which was conﬁrmed by 3H-palmitate
labeling (Supplementary Fig. 1e). Accordingly, deletion of the
CXXC motif (ΔN4) reduced microvilli localization in both 293 T
and Jurkat T cells (Supplementary Fig. 1f), suggesting a critical role
of palmitoylation for Vstm5 localization at microvilli.
Vstm5 had minimal effects on T cell activation (Supplementary
Figs. 2a and b), presumably because proteins with low expression
normally would not be expected to signiﬁcantly alter cellular
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functions. We also generated a CRISPR/Cas9-based Vstm5-
knockout mouse (Vstm5−/−; Supplementary Figs. 2c and d)
and found that Vstm5−/− T cells presented normal microvilli
(Supplementary Fig. 2e), whereas the cells showed slightly
reduced interleukin (IL)-2 production, but only when T cells
were incubated with staphylococcal enterotoxin B (SEB)-loaded
CD19+ B cells (Supplementary Fig. 2f). Taken together, these
results demonstrated that Vstm5 is a useful probe for microvilli
study. Similar to the EM study, V5G signals reﬂected the presence
of microvilli during all stages of T cell activation (Fig. 2c). At the
bottom of late-stage T cells, V5G was signiﬁcantly co-localized
with F-actin (Fig. 2d), indicating that V5G+ microvilli consisted
of actin bundles. In the terminal stage, we observed a number of
rod- or round-shaped microvilli particles that were scattered
around the cells (Fig. 2e, white box), and real-time separation of
microvilli from the T cell body was clearly visible under total
internal reﬂection ﬂuorescence microscopy (TIRFM) (Fig. 2f and
Supplementary Movie 1). Using V5G and, in some cases,
TSPAN25, we determined how microvilli move during IS
formation/deformation and release from the T cell body.
Microvilli bring TCR clusters to the central (c)SMAC. We
initially determined the 3-dimensional dynamic movements of
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Fig. 1 T cells generate microvillus-originated particles upon TCR stimulation. a T cell microvillus polarization toward antigen-bearing B cells at the early
stage of IS. SEM of resting single (left) or two adjacent (right) Jurkat T cells on PLL (i) and co-incubated with SEE-loaded Raji B cells (5, 30min) (ii). Arrows
indicate microvilli (red) and membrane rufﬂes (blue). b, c SEM of OTII naive CD4+ T cells on PLL with the anti-CD3 antibody (b) or OVA peptide/I-Ab and
ICAM-1 (c) at various time points. Early (early stage, 1 min), mature (1–5 min), late (10–20min), and terminal stages ( > 20min). d Jurkat T cells were
placed on anti-CD3-coated coverglass for 30min and observed by TEM. The areas of TMPs and mitochondria were quantitated using ImageJ software.
*P < 0.01 vs. mitochondria
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Fig. 2 T cells generate V5G+ microvilli particles on anti-CD3-coated surfaces. a V5G+ Jurkat T cells were imaged by confocal microscopy and color-coded
by z-position (left). Comparison of V5G ﬂuorescence intensity between microvillus shaft and membrane surface (right). b Co-localization of V5G with F-
actin. V5G+ Jurkat T cells on PLL were stained with TRITC-phalloidin. c Confocal images of V5G+ Jurkat T cells on anti-CD3-coated coverglass. Cells were
monitored for 60min, and representative images of each stage are shown. d Co-localization of V5G+ microvilli with F-actin. V5G+ Jurkat T cells on anti-
CD3-coated coverglass and incubated for 20min to 30min were stained with TRITC-phalloidin. The ﬂuorescence intensity proﬁles from a and b were
analysed with ZEN v2.1 (for a, b, and d; Carl Zeiss). e Separated V5G+ microvilli particles are colored at the terminal stage. f Real-time V5G+ microvilli
particles generation from activated T cells. V5G+ Jurkat T cells on anti-CD3-coated coverglass were observed by TIRFM (see also Supplementary Movie 1).
g Jurkat T cells expressing V5G and TCRζ_ptdTomato were placed on anti-CD3-coated coverglass for 30min. Protein localization at the terminal stage of T
cell activation was determined. For LAMP-1 imaging, primary and secondary antibodies were used
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microvilli during T cell interactions with antigen-loaded APCs or
an anti-CD3-coated surface. Similar to the scanning EM (SEM)
study, V5G+ microvilli polarized toward the contact site of a T
cell and a B cell at the early stage of IS and moved into the
cSMAC at the mature stage (Supplementary Fig. 3a), Interest-
ingly, at the mature stage, V5G signals were seen as puncta and
highly co-localized with F-actin spots at the cSMAC (Supple-
mentary Fig. 3b and Supplementary Movie 2), with these spots
possibly representing actin bundles that are the main components
of microvilli (Supplementary Fig. 3b, white arrowheads). These
results suggested that microvilli do not collapse during IS
maturation19,20, but instead are scattered around the cells
(Figs.1b–d 2e, f; Supplementary Movie 1) or moved into the
cSMAC (Supplementary Figs. 3a and b). A potential mechanism
for how microvilli disappeared from the dSMAC, moved toward
the cSMAC with TCR clusters during IS formation, and reap-
peared after synapse breakage is depicted in Supplementary
Fig. 3c.
Because a recent report demonstrated that TCRs are clustered
at microvilli tips12, we determined whether microvilli contain
TCRs. TCR ζ-chain signals were clearly observed at the tip of
V5G+microvilli during the late stage of activated T cells (Fig. 2g).
By contrast, lysosomal-associated membrane protein (LAMP)-1,
a late endosomal marker, was almost excluded from microvilli
(Fig. 2g). These results logically suggested that microvilli
separated from the T cell body might contain a considerable
number of TCR complexes and allied proteins.
To overcome weaknesses associated with antibody based work,
we adopted a lipid-bilayer system presenting I-Ab MHC class II
and ICAM-1 and hypothesized that if centralization of the TCR
clusters depends upon the movement of microvilli, both TCRs
and V5G (or TS25G) should be observed together on the lipid
bilayers. To this end, OTII TCR CD4+ T cells were transfected
with V5G (or TS25G), and their movements were observed in
combination with TCRβ under TIRFM. Both proteins were
observed as puncta and moved similarly toward the cSMAC
(Fig. 3a, Supplementary Movie 3, and Supplementary Fig. 4a).
These processes were completely dependent upon the intact actin
cytoskeletons, as disruption of surface microvilli by actin
modulators reduced cSMAC formation (Fig. 3b).
Increased TCR+ TMPs release during T cell kinapse. T cells
engage in two modes of interaction with antigen-presenting
surfaces: stable synapses and motile kinapses21. Interestingly, a
recent report demonstrated that all major T cell subsets spend
more time in the kinapse mode, and that durable interactions for
priming do not require stable synapses22. Therefore, we deter-
mined which mode of T cells produce more TMPs. In the pre-
sence of the OVA323-339 peptide, most OTII CD4+ T cells
formed strong synapses (Supplementary Fig. 4b); however, cells
in the synaptic period released relatively few TCRβ+ TMPs
(Fig. 3c). By contrast, interestingly, T cells in kinapses produced
additional TCRβ+ TMPs behind them (Fig. 3c, d, Supplementary
Fig. 4b and c, and Supplementary Movie 4; arrowheads). The
particles were irregular in their forms and larger than exosomes
(L-TMPs; diameter: 20–500 nm); however, EM analysis showed
that regular- and small-exosome-sized TMPs (S-TMPs; diameter:
20–40 nm) were also present in the inner area of the T cell under
the transition period between synapse and kinapse, and that this
area was surrounded by L-TMPs (Fig. 3e). The existence of S-
TMPs suggests that previously reported TCR-enriched micro-
vesicles10 were budded from microvilli, which accumulated at the
cSMAC (Fig. 3a). However, the fact that additional L-TMPs were
released from T cells in kinapses strongly demonstrated that the
cSMAC is not a secretory domain of microvesicle release. Instead,
the microvillus itself provided a secretory microdomain for TMP
productions. Additionally, generation of TMPs required adhe-
sion, as they were only signiﬁcantly generated on the anti-CD3-
coated surface or planar lipid bilayers presenting peptide-MHC
and ICAM-1 (Fig. 3f). These results suggested that TMP gen-
eration required TCR signaling, as well as receptor-mediated T
cell adhesion on the surface of antigen-bearing APCs.
We then conﬁrmed the generation of TMPs during T cell
interaction with APCs. Microvillar projection is not easily
observed in vivo, as microvilli on the surface of T cells are too
thin and short. However, if a T cell truly contacts APCs via
microvilli, we expected that the T cell would form multiple
bridges with APCs due to the numerous surface microvilli, which
differs from membrane nanotubes, only a few of which are
observed between connected cells23. Here, viral transduction of
V5G enabled us to monitor microvilli extending from the T cell
surface. As expected, although a single OTII CD4+ T cell bound
mainly to one B cell or one DC in the presence of antigen
(OVA323-339), this cell also formed multiple bridges with other
surrounding B cells or DCs (Fig. 4a).
To determine how multiple bridges are formed and TMPs are
generated under live conditions, CD4+ T blast cells expressing
V5G were incubated with SEB-loaded DCs and monitored under
a live-cell imaging microscope. Time-lapse imaging unambigu-
ously revealed that T cells formed multiple bridges on the surface
of DCs during T cell movement (Fig. 4b, Supplementary Movies 5
and 6). Additionally, L-TMPs were obviously generated from the
elongated T cell microvillar tails (Fig. 4b, panel (i)), with some
DC particles detaching and moving along with the T cell
microvillar tail (Fig. 4b, panel (ii), yellow arrowheads; and
Supplementary Movie 6), possibly suggesting that such particles
were derived from DC microvilli, which are known to
preferentially present MHC class II molecules24,25. The same
results were also obtained when OTII CD4+ T cells interacted
with OVA-loaded DCs or B cells (Fig. 4c). To determine whether
the separation of V5G+-microvilli is integrin-dependent, we used
T cells from lymphocyte function-associated antigen-1 (LFA-1)-
knockout mice26. Because LFA-1−/− T cells signiﬁcantly lose their
ability to bind to ICAM-1+ DCs, we also investigated the ability
of LFA-1+/− T cells (heterozygotes) to generate V5G+ MPs, as
these cells retain partial binding capacity toward ICAM-1+ DCs
(Fig. 4d). However, neither LFA-1−/− nor LFA-1+/− T cells left
residual V5G+ TMPs, suggesting that the high-afﬁnity state of
LFA-1 is a prerequisite for optimal microvilli disconnection.
L-TMPs are further fragmented by the budding complex. The
release of TMPs from the T cell body suggests that these particles
might comprise a vector specialized for intercellular commu-
nication. However, the remaining question was how large TMPs
can be and remain capable of transfer to interacting cells without
size reduction, as some rod-shaped particles are larger than a few
micrometers. Surprisingly, we found that V5G+ microvilli were
further fragmented during and after disconnection from T cells in
kinapses (Fig. 5a). Additionally, SEM analysis revealed that S-
TMPs were generated from microvillar stalks and tips of moving
or spread T cells (Fig. 5b, c, cyan blue arrows), suggesting that
another mechanism in addition to adhesion-dependent trogocy-
tosis is involved in converting L-TMPs to S-TMPs. The inter-
mediate forms between microvilli and microparticles were easily
observed by SEM analysis of OTII CD4+ T cells on planar lipid
bilayers presenting OVA peptide/I-Ab and ICAM-1 (Fig. 5b).
Therefore, we determined the size of TMPs after puriﬁcation, as
depicted in Supplementary Fig. 5a. Surprisingly, the diameters of
TMPs following puriﬁcation ranged from 20 nm to 100 nm,
which is comparable to the size of exosomes4 and was similar to
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06090-8 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:3630 | DOI: 10.1038/s41467-018-06090-8 | www.nature.com/naturecommunications 5
human and mouse T cells (Fig. 5d). Moreover, we observed that
TMPs exhibited small and round-shaped morphologies (Fig. 5d).
To identify proteins, puriﬁed TMPs were subjected to liquid
chromatography tandem mass spectrometry (LC-MS/MS), with
unsupervised hierarchical clustering analysis and principal com-
ponent analysis (PCA) used to identify similarities and
differences in the whole proteome among total, vesicle, mem-
brane, and TMP groups. The TMP and membrane groups clus-
tered closely together but distal from the total and vesicle groups,
indicating that the TMP group exhibited a proteomic pattern
close to that of the membrane group (Fig. 6a). The proteins that
were commonly detected in three independent experiments in the
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total, membrane, TMP, and vesicle groups were selected (Sup-
plementary Data 1), and western blots were performed to identify
the presence of T cell proteins identiﬁed by LC-MS/MS. Strik-
ingly, TMPs exclusively contained a large amount of direct
plasma-membrane budding (DPMB) complex components, such
as Arrdc1, TSG101, and Vps4 a/b (Fig. 6b,c). Notably, Arrdc1
plays a pivotal role in DPMB, an intrinsic cellular process that
underlies multivesicular-body independent vesicle formation at
the cell surface8. Arrdc1 was highly concentrated at microvilli tips
(Fig. 7a, arrowheads), and TSG101 was observed in the cytoplasm
in multiple punctate foci, as is characteristic of endosome-
associated localization8. However, TSG101 was redistributed to
the microvilli when co-expressed with Arrdc1 (Fig. 7a). Inter-
estingly, Arrdc1 was clearly co-localized with TCR clusters and
moved toward the c-SMAC during IS maturation (Fig. 7b), fol-
lowed by its release as a TMP upon T cell movement to form
additional contacts on the lipid bilayer (Fig. 7c). Furthermore, the
TCR ζ-chain was recovered with the Arrdc1-enriched fractions
after ultracentrifugation of the sucrose gradient (Fig. 7d)27.
Knockdown of either Arrdc1 or Vps4 showed little effect on the
morphology of microvilli on the T cell surface (Fig. 7e), whereas
many elongated microvilli tails or long rod-shaped microvilli
particles were observed in T cells (Fig. 7f, g). Accordingly, TMP
generation was signiﬁcantly reduced (Fig. 7g), and TMPs were
also signiﬁcantly reduced in the absence of ICAM-1 on the lipid
bilayer presenting OVA peptide/I-Ab (Fig. 7h and Supplementary
Fig. 6), suggesting that trogocytosis mediated by the LFA-
1–ICAM-1 interaction, as well as membrane-budding reactions,
were not independent processes, but cooperated to produce
additional TMPs. Evaluation of the effects of various other anti-
bodies, including anti-LFA1, anti-MHC, anti-CD43, and anti-
CD44, revealed that none were involved in TMP generation
(Fig. 7i), suggesting that TMP release was speciﬁcally associated
with response to TCR activation.
TMPs from CD4+ T cells activate DCs independent of MHC.
Both proteomics and western blot analyses revealed that TMPs
exclusively contained important T cell proteins, including the
TCR complex (TCRα/β and CD3ε, γ, and ζ-chains) and costi-
mulatory molecules, such as CD2 (LFA-2) and CD28 (Fig. 6b, c).
These results implied that TMPs play a physiological role in
cellular interactions. In agreement with this hypothesis, TMPs
from OTII CD4+ T cells (4-TMPs) deposited on the lipid bilayer
strongly induced sustained calcium response in DCs (Fig. 8a and
Supplementary Fig. 7a–c); however, we observed that calcium
signaling was initiated, even when DCs were not loaded with
OVA peptide, suggesting that DC activation by 4-TMPs is
independent of cognate TCR–MHC signaling. To rule out the
inﬂuence of OVA peptide remaining on the lipid bilayer, we
examined whether 4-TMPs puriﬁed from the anti-CD3-coated
surface also evoked the same physiological DC responses as 4-
TMPs on the lipid bilayer. To this end, 4-TMPs puriﬁed from the
anti-CD3-coated surface (Supplementary Fig. 5a) were incubated
with DCs in the presence or absence of SEB. The calcium
response was observed regardless of SEB (Fig. 8b), indicating that
the effect was independent of cognate TCR–MHC engagement.
Moreover, DCs from Toll-like receptor (TLR)4-knockout
(TLR4−/−) mice did not respond to lipopolysaccharide (LPS)
stimulation, but their calcium levels were signiﬁcantly upregu-
lated by 4-TMPs, demonstrating that the effect of 4-TMPs was
independent of LPS signaling (Fig. 8b). Additionally, 4-TMPs
induced the expression of costimulatory molecules, such as CD40,
CD80, and CD86, in DCs (Fig. 8c, d). In general, 4-TMPs col-
lected from T cells were sufﬁcient to activate DCs at a ratio of 1:1
(T cell:DC) (Fig. 8c). Furthermore, blocking the Fc gamma
receptor (FcγR) had little effect on DC activation, suggesting no
inﬂuence by anti-CD3 antibodies used to purify 4-TMPs
(Fig. 8d).
We then determined whether TMPs are important in the
selective activation of physically interacting (or cognate) APCs or
whether they are involved in the activation of bystander APCs.
We employed a transwell chamber with a 0.4-μm pore size that
allows TMPs but not T cells and DCs. OTII CD4+ T cells and
DCs were incubated in the absence (−) or presence (+) of
OVA323-339 (Fig. 9a). Because noncovalent protein-protein
interactions, such as antibody binding, can be dissociated by
acid buffer treatment28, we measured the surface transfer of T cell
microvillar proteins, including TCR and V5G, on DCs after acid
washing (Supplementary Figs. 8 and 9a). V5G+ and TCR+ signals
were only observed in DCs directly incubated with OTII CD4+
T cells in the presence of OVA peptide (Fig. 9a), suggesting that
4-TMPs released by peptide-speciﬁc CD4+ T cells stably bind
only to the surface of cognate antigen-bearing DCs. Consistently,
the upregulation of costimulatory molecules was observed in V5G
+ or TCR+ DCs (Fig. 9a), with similar results obtained using
antibody puriﬁed 4-TMPs (Fig. 9b). These results strongly
demonstrated that physical contact between TMPs and the DC
surface was critical for TMP-mediated DC activation. To validate
in vivo evidence of antigen-dependent TMP transfer (or TCRβ+
particles), we injected either OVA257-264 (MHC class I) or
OVA323-339 (MHC class II) peptides into OTII TCR transgenic
mice and evaluated the expression of TCRβ+ on the surface of
DCs. Signiﬁcant levels of TCRβ were only observed on DCs from
OVA323-339- but not OVA257-264-injected mice, demonstrat-
ing that TMPs were transferred into the cognate DCs in vivo
(Fig. 9c).
Along with the transfer of TCRs, we also determined the
transfer of other membrane T cell proteins onto the surface of
Fig. 3 TCR-enriched microvillus particles are released to a greater extent during T cell kinapse mode. a Co-localization of V5G with TCR microclusters. V5G
+ OTII CD4+ T cells were stained with anti-TCRβ (H57Fab-Alexa594) and examined on a planar bilayer presenting OVA peptide/I-Ab and ICAM-1 (see
also Supplementary Movie 3). Relative time scales starting from the time of cell spreading are labeled on the images. Representative trajectory of individual
TCR microclusters are shown in the right panel. b V5G+ OTII CD4+ T cells were pretreated for 30min with (Lat A; 237 nM), JAS (100 nM), and CK636
(100 μM), followed by SEM (left) and TIRFM imaging to visualize V5G+ microvillus movement on the lipid bilayer (middle). Boxed regions are shown
enlarged at the bottom of the panels. Representative trajectories of individual V5G clusters (bottom). Statistical analyses of the frequency of cSMAC
formation and the number of V5G clusters in OTII CD4+ T cells (right). *P < 0.05 vs. none. Data represent the mean of three experiments ± SEM.
c, d Release of TCR+ TMPs during synapse and kinapse. V5G+ OTII CD4+ T cells were stained with anti-TCRβ (H57Fab-Alexa594) and observed on a lipid
bilayer presenting OVA peptide/I-Ab and ICAM-1 by TIRFM (see also Supplementary Movie 4). The numbers of TCRβ+ TMPs were quantitated using
ImageJ software (c). *P < 0.01 vs. no antigen (No-Ag). Data represent the mean of three experiments ± SEM. e L- and S-TMP release during synapse and
kinapse. Cells from (d; synapse–kinapse) were subjected to SEM analysis. P, pSMAC; C, cSMAC. Particle diameters were analysed using 500 particles in
the C and P of a single cell, and > 30 cells were examined. Data represent the mean of three experiments ± SEM. *P < 0.001 vs. C. f TMP generation from
OTII CD4+ T cells was examined in each condition. Cells were subjected to SEM, and the number of TMPs per cell was analysed using ImageJ software.
Data represent the mean of three experiments ± SEM. *P < 0.001 vs. PLL
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DCs. We observed a signiﬁcant increase in T cell proteins, such as
CD4, CD28, CD2, and CD25, but not CD40L, on the surface of
DCs (Fig. 10a). Because costimulatory proteins on the T cell
surface induce signals that affect APC activation and/or
maturation29,30, we further determined whether some of the
costimulatory proteins observed by LC-MS/MS analysis con-
tributed to 4-TMP-mediated DC activation. To this end, we
employed blocking antibodies that interfere with CD2/CD58,
CD40L/CD40, and LFA-1/ICAM-1 interactions. Antibodies
against CD2 and LFA-1, but not CD40L (present at low levels
in TMPs), clearly reduced DC activation (Fig. 10b); however, the
lack of complete inhibition of calcium signaling suggested that
several factors in TMPs might be involved in the activation of
DCs. Because some cytokines, such as tumor necrosis factor
(TNF)-α31 and IL-432, also activate DCs, we determined the levels
of cytokines or secretory proteins in 4-TMPs and compared these
with levels observed in total cell lysates. Cytokine array revealed
that TMPs were enriched with various T cell cytokines (Fig. 10c),
among which we determined the levels of IL-3333, TNF-α31, IL-
432, and IL-734, which regulate DC activation or maturation.
These results indicated that several factors in TMPs regulate the
activation of DCs.
Discussion
Although many reports have documented that immune cells can
extract surface molecules through the IS to which they are
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conjugated, the site of surface extraction, as well as the associated
molecular mechanisms, remain unknown. In this study, we
demonstrate that T cell microvilli are membrane organelles that
are highly fragile to extraction when two cells separate. Surpris-
ingly, membrane particles derived from T cell microvilli (i.e.,
TMPs) are enriched with many immunologically relevant pro-
teins, including the TCR complex, and play a role as vectors to
provide T cell messages or traits to physically interacting APCs.
Until now, the general importance of microvilli present on the
surface of lymphocytes has been strongly underestimated, and
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their essential functions remain unrecognized. We found that the
early onset of T cell antigen recognition includes the extension of
microvilli toward the cell that the T cell is recognizing. Using
speciﬁc GFP-tagged probes, we monitored microvilli at all stages
of T cell activation, ﬁndings that TCRs were segregated on
microvilli tips, as recently reported12, and also centralized to the
cSMAC along with movement of the microvilli. We then found
that large TCR-enriched TMPs (L-TMPs) were separated from
the T cell body via trogocytosis and then scattered around the
cSMAC or behind the moving T cells. Surprisingly, the particles
were further fragmented by membrane-budding complexes, such
as Arrdc1, TSG101, and vps4, which were also enriched at the
microvilli tips, and formed typical exosome-sized S-TMPs.
Immunologically important T cell molecules were selectively
concentrated at the microvilli tips and in separated TMPs, which
enabled TMP-mediated control of the activation state of
physically interacting DCs and suggested that TMPs constitute
“immunological synaptosomes” that serve as a conveyors of T cell
immunologic transmission.
A previous report demonstrated that extracellular membrane
particles carrying the stem cell marker prominin-1 (CD133) are
released from the microvilli of neural progenitors and epithelial
cells14,35. Additionally, a recent report demonstrated that primary
and motile cilia/ﬂagella, which function as cellular antennae, also
produce ectosomes36, suggesting that membrane-protrusive
regions, such as microvilli and cilia/ﬂagella, could be the sour-
ces of membrane particles. However, generation of these mem-
brane particles was not dependent upon cell–cell contact, but
rather they were released through secretion via an unidentiﬁed
mechanism. Therefore, the release of contact/adhesion-dependent
TMPs is a unique and novel system and more highly related to
trogocytosis than to vesicle secretion in activated T cells.
Fig. 5 L-TMPs undergo morphological changes during and after disconnection from the cell body and are comparable in size to exosomes. a Fragmentation
of V5G+ microvilli particles during and after disconnection from T cells in kinapse on a lipid bilayer (yellow arrows= fragmented sites; blue arrows= sites
yet to be fragmented). bMicrovillus-originated particles in the process of fragmentation. Cells from (a) were observed by SEM. Yellow arrows indicate the
cleavage of L-TMPs into S-TMPs (1). Cyan blue arrows indicate the pre-cleavage sites in the microvilli (2) and L-TMPs (3). c SEM analysis of TMPs
generated from CD3+ T cells on anti-CD3-coated coverglass. Yellow arrows indicate the cleaved TMPs from microvilli. Cyan blue arrows indicate TMPs
budding from microvilli tips. dMouse and human TMPs were harvested as described in Supplementary Fig. 5 and observed by SEM and TEM. The area and
roundness of TMPs from human and mouse T cells were measured using ImageJ and Imaris software, respectively. Data represent the mean of three
experiments ± SEM
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However, it is inappropriate to attribute this exclusively to tro-
gocytosis, because the membrane-budding machinery is also
involved in the cleavage of large microvillar fragments from S-
TMPs. From this viewpoint, it would be interesting to compare
the mechanisms associated with TMP generation with those of
recently identiﬁed membrane vesicles, such as neutrophil trails37
and migrasomes38, as these two vesicles also require membrane
contact with adhesion molecules or matrix in order to be
generated37,38. Contact-dependent transfer of membrane particles
has at least two merits. First, it can rapidly transfer the messages
of donor cells to recipient cells. Second, this method can only
transmit signals between physically interacting cells, thereby
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minimizing their inﬂuence on bystander cells. Therefore, we
propose that, as opposed to exosomes and ectosomes, which are
recognized as important mediators of long-distance intercellular
communication, TMPs, as well as neutrophil trails and migra-
somes, should be categorized as a new class of extracellular
vesicles.
In this study, we found many short- or long-bridges between
each T cell and surrounding antigen-loaded APCs. Indeed, these
bridges might represent a structure similar to that of membrane
nanotubes, which connect a wide variety of cells, including
T cells, natural killer cells, B cells, and macrophages23,39–41.
Therefore, it is necessary to revisit the process of nanotube for-
mation. Previous reports suggest that nanotubes are formed de
novo by membrane protrusions in a process driven by the actin
cytoskeleton23. However, if nanotubes originate from microvilli,
membrane nanotubes might not be generated de novo, but rather
could be elongated by the “pulling force” when two synaptic cells
separate. Moreover, unequivocal evidence for nanotube-mediated
exchange of proteins between immune cells is still lacking.
We observed that TMPs were only transferred to the surface of
physically interacting DCs and showed little effect on bystander
DCs, suggesting that TMPs are primarily required for cognate DC
activation. However, if TMPs are truly critical for DC activation,
why do T cells need stable synapses for DC activation, as DC
activation occurs within a stable IS via cognate TCR–MHC
interaction along with roles involving a variety of cell–cell signals,
CD40/CD40L interactions, cytokines, and adhesion molecules? A
recent report demonstrated that all major subsets of T cells spend
more time in kinapse mode on continuous stimulatory surfaces22.
This is interesting, because the report suggests that activation of
either T cells or DCs does not necessarily require a stable synapse
if there is a strong interaction between cognate T cells and DCs.
In this situation, mutual exchange of message-containing vectors
between two cells could be more efﬁcient for sustaining activa-
tion. Moreover, it has been demonstrated that T cell and DC
synapses comprise several tens of submicronic contact spots and
lack the large-scale concentric organization characteristic of
prototypical synapses42,43, suggesting that it is inappropriate to
consider the concentric structure as a mature synapse and mul-
tifocal structures as immature42.
Another major question concerns whether DC activation by
TMPs is transduced by cognate TCR–MHC interaction or other
mechanisms. First, full DC activation by 4-TMPs puriﬁed from
antibody (CD3)-activated CD4+ T cells clearly indicated that DC
activation was not mediated through MHC class II molecules,
whereas T cells require cognate MHC-peptide recognition for
activation. In agreement with our results, many reports show that
MHC class II signaling does not play a role in DC activation,
whereas antigen-speciﬁc T cell interaction might contribute via
other mechanisms to regulate DC activation44–46. Indeed, MHC
class II signaling is coupled with the induction of rapid cell death
and plays opposing roles to CD40 in DC survival. However, in
this regard, our results differed from those of a previous report
demonstrating that B cell-speciﬁc calcium signaling triggered by
TCR-enriched microvesicles is dependent upon speciﬁc interac-
tions between TcrAND present on microvesicles and cognate
moth cytochrome c-I-Ek complexes10. This discrepancy might be
due to the fact that DCs and B cells are activated in different
ways. Indeed, several reports indicate that B cell activation
requires contact-mediated signals from T cells47, with the ﬁrst of
such signals identiﬁed as involving MHC class II molecules48,49.
Enrichment of CD2 in TMPs, as well as the signiﬁcant
reduction of calcium responses in 4-TMP-treated DCs following
use of an anti-CD2 antibody, demonstrated that CD2 plays an
important role in DC activation. In agreement with this ﬁnding,
CD2 the physiological trigger of human monocyte TNF and IL-1
release29; however, the lack of complete blockage of calcium
response by the anti-CD2 antibody suggested the involvement of
other factors in DC activation. Indeed, TMPs are enriched with
many important T cell proteins, including membrane proteins
and cytokines, among which IL-33, IL-4, IL-7, and TNF-α are
well-known regulators of DC activation or differentiation31–34.
However, because some cytokines, such as IL-1ra and IL-10,
reportedly downregulate DC functions, more cautious observa-
tions are required. Furthermore, TMPs, like exosomes, can also
contain genetic information, such as coding and noncoding
RNAs, able to transfer T cell messages to recipient cells50. Further
studies are underway to determine the mechanisms of TMP
internalization and their control of DC activation.
In conclusion, lymphocytes are highly specialized cells that
circulate throughout the entire body to scan a speciﬁc antigen and
deliver messages to target cells. Because of their dynamic motility,
lymphocytes might have evolved to harbor specialized mechan-
isms to promote communication between interacting cells, even
under mobile conditions. Therefore, microvillus-derived message
transfer might be a unique means of communication for lym-
phocytes or immune cells and not cells occupying tissues. A
schematic model describing TMP generation during T cell
synapse and kinapse is shown in Supplementary Fig. 9. A detailed
understanding of how TMPs are exchanged between immune
cells would permit therapeutic exploitation of these vesicles,
resulting in their potentially serving as promising vectors for
immunotherapy in diseases of the immune system and other
scenarios.
Methods
Reagents and antibodies. Antibodies against calcium pump pan PMCA ATPase
(ab2825), Calnexin (ab22595), Vstm5 (ab179816), sodium potassium ATPase
(ab58475), LAMP (ab24170), Arp3 (ab181164), CD2 (ab219411), CD40 ligand
(ab52750), CD28 (ab205136), Arrdc1 (ab123600), Vps4a/b (ab229806, ab224736),
Fig. 7 L-TMPs are further fragmented by membrane-budding complexes. a Localization of Arrdc1 and TSG101 in the microvillus tips of HEK293T cells.
Arrdc1_GFP was represented with pseudo-color coding according to ﬂuorescence intensity. Cropped images from selected microvilli (yellow arrows) are
displayed from i to v (left). Recruitment of TSG101 to the membrane in Arrdc1-overexpressing cells (right). b Co-clustering of Arrdc1_GFP and TCRβ into the
cSMAC. Arrdc1_GFP+ OTII CD4+ T cells were stained with anti-TCRβ (H57Fab-Alexa594) and examined as described in Fig. 3a. Images were selected at
300-s post-recording, and the representative trajectories are shown in the bottom panel. c Release of TCR+/Arrdc1_GFP+ TMPs during the
synapse–kinapse transition stage. Arrdc1_GFP+ OTII CD4+ T cells were stained with anti-TCRβ and observed as described in Fig. 3d. d Puriﬁed TMPs were
ultracentrifuged with a sucrose gradient and blotted with anti-Arrdc1, anti-CD3ζ, and anti-β-actin (lanes 1–6, sucrose fraction; P, pellet). e Knockdown of
Vps4 and Arrdc1 by siRNA and conﬁrmation of siRNA efﬁciency by western blot analysis. Surface analysis of CD4+ T cells by SEM after knockdown of the
indicated proteins. f, g Representative SEM analysis of Vps4-deﬁcient OTII CD4+ T cells on the lipid bilayer (f). Particle diameters and numbers of TMPs
per cell were analysed by ImageJ software (g). Data represent the mean of three experiments ± SEM. *P < 0.05 vs. scrambled (Sc., left) or scrambled
(20–40 nm, right) siRNA. **P < 0.001 vs. scrambled siRNA (40–100 nm). h TCR+ TMP release on an OVA peptide/I-Ab lipid bilayer with or without
ICAM-1. The number of TCR+ TMPs per cell was analysed by ImageJ software. Data represent the mean of three experiments ± SEM. *P < 0.001 vs.
pMHC/ICAM-1. i TCR+ TMP release on plates coated with various antibodies. Data represent the mean of three experiments ± SEM. *P < 0.001 vs. PLL
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and TSG101 (ab125011) were purchased from Abcam (Cambridge, MA, USA).
Antibodies against TCRα (sc-9100), TCRβ (sc-73121), CD3ζ (sc-1239), CD3ε (sc-
137095), CXCR4 (sc-53534), CD43 (sc-7054), and MHC class I (sc-59199) were
purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Antibodies against
Rab5 (3547), HSP90 (4877), LCK (2752), phospho-LCK (2751), Fyn (4023), ZAP70
(2705), Syk (13198), phospho-paxillin (2541), phospho-Akt (4060), β-actin (8457),
Rab11 (3539), anti-rabbit IgG (7074), and anti-mouse IgG (7076) were obtained
from Cell Signaling Technology (Danvers, MA, USA). All primary antibodies for
western blot were used at a dilution of 1:1000. Alexa Fluor 647-conjugated anti-
human LAMP-1 (328611), allophycocyanin-conjugated anti-CD11a (141009), anti-
CD44 (103011), and anti-CD2 (100111) antibodies were obtained from BioLegend
(San. Diego, CA, USA). Anti-FcγR blocking antibody (553141; 1 µg per million
cells in 100 µL) was purchased from BD Biosciences (San Jose, CA, USA). Anti-
TCRβ (H57-597) and anti-CD154 (MR-1) were purchased from Bio-X-Cell (West
Lebanon, NH, USA). Fab preparation kit was purchased from Thermo Fisher
Scientiﬁc (Waltham, MA, USA). Antibodies for ﬂuorescein isothiocyanate-
conjugated CD40 (MA5-16506), MHCII (11-5322-82), CD11a (11-0111-82),
phycoerythrin-conjugated CD86 (12-0862-82), CD80 (12-0801-82), CD25 (12-
0251-82), CD11c (MCD11c04), allophycocyanin-conjugated CD4 (17-0041-82),
CD40L (17-1541-82), CD11c (17-0114-82), and PercpCy5.5-conjugated CD28
(45-0281-80) were purchased from eBioscience (San Diego, CA, USA). All anti-
bodies for ﬂow cytometry were used at a dilution of 1:100. Proteome Proﬁler
Mouse Cytokine XL array kit and mouse-TNFα, -IL-4, and -IL-7, and -IL-33
cytokine DuoSet enzyme-linked immunosorbent assay (ELISA) kits were pur-
chased from R&D Systems (Minneapolis, MN, USA). Avidin, tetra-
methylrhodamine (TRITC)-phalloidin, poly-L-lysine (PLL), anti-rabbit IgG-
TRITC, A23187, and phorbol 12-myristate 13-acetate (PMA), latrunculin A (Lat
A), jasplakinolide (JAS), and CK636 were purchased from Sigma-Aldrich (St.
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Fig. 8 4-TMPs activate DCs regardless of TCR engagement. a Representative confocal images of Fluo-3-loaded DCs placed on a 4-TMP-deposited lipid
bilayer. b Fluo-3-loaded DCs from wild type or TLR4−/− mice were stimulated with 4-TMPs puriﬁed from CD4+ T cells in the presence or absence of SEB.
Calcium changes were analysed by ﬂow cytometry for 300 s. Data are representative of at least three separate experiments. c Surface protein expression
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Louis, MO, USA). Alexa594-labeling kit, Lipofectamine 2000, Fluo-3/AM, Cell-
Tracker CMFDA-green, CMRA-Orange, and Deep Red dyes were purchased from
Invitrogen (Carlsbad, CA, USA). Hybridoma cell lines for mouse anti-CD3 (145-
2C11; CRL-1975), mouse anti-CD28 (PV1; HB-12352), and anti-human CD3
(OKT3; CRL-8001) were purchased from the American Type Culture Collection
(Manassas, VA, USA). Anti-human ICAM-1-His stable S2 cell line was a gift from
Dr. M.L. Dustin (The Kennedy Institute of Rheumatology, Oxford, UK).
Staphylococcal enterotoxin E (SEE) and SEB were purchased from Toxin Tech-
nology, Inc. (Sarasota, FL, USA). OVA peptide fragments (323–339 and 257–264)
were purchased from GeneScript (San Francisco, CA, USA). Reverse transcription
PCR premix and restriction enzyme were purchased from Enzynomics (Daejeon,
Korea). Plasmid DNA puriﬁcation kit and WEST-ZOL western blot detection kit
were purchased from Intron Biotechnology (Seongnam, Korea). PrimeSTAR HS
DNA polymerase was purchased from TaKaRa Bio (Shiga, Japan). Endo H and
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The expression of MHC class II, CD80, CD86, and CD40 on DCs (CD11c+) was analysed by ﬂow cytometry and expressed as histograms and mean
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with DCs as depicted in the schematic diagram (left) and incubated as described in a. TCRβ, CD86, and CD40 presentation on DCs (CD11c+) was analysed
as described in a. Data represent the mean of three experiments ± SEM. *P < 0.01 vs. c. c Transfer of TCRs to DCs in vivo. OTII TCR transgenic mice were
administered OVA257-264 and OVA323-339 (100 μg; i.p.) in PBS, respectively. After 48 h, draining lymph nodes were taken and dissociated, and cells
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Fig. 10 CD2/CD58 and LFA-1/ICAM-1 play important roles in TMP-mediated DC activation. a DCs (5 × 106) were treated with either PBS or 4-TMPs (5 ×
107) for 2 h, and the transfer of indicated proteins on DCs (CD11c+) was analysed by ﬂow cytometry. Data represent the mean of three experiments ± SEM.
*P < 0.01 vs. no 4-TMPs. b Fluo-3-loaded DCs (5 × 106) were pretreated for 30min with the indicated blocking antibodies (anti-CD2, -CD40, and -LFA-1),
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PNGase F were purchased from New England Biolabs (Ipswich, MA, USA). Len-
tiviral vector for LifeAct_mRFP was purchased from Ibidi (Verona, WI, USA).
TSG101, Vps4a-, Vps4b-, and Arrdc1-targeting and scrambled control small-
interfering (si)RNAs were purchased as a pool of four siRNA duplexes from
Dharmacon (Lafayette, CO, USA). Blocking peptides for anti-CD2 and -CD3ε were
purchased from MyBioSource (San Diego, CA, USA). MHC I-Ab was provided by
the NIH Tetramer Core Facility (Atlanta, GA, USA). Amaxa Nucleofector II and
the Mouse T Cell Nucleofector kits were purchased from Lonza (Walkersville, MD,
USA). Complete protease inhibitors and phosphatase inhibitors were purchased
from Roche Applied Science (Indianapolis, IN, USA). Transwell apparatus (0.4 μm)
were purchased from Costar (Corning, NY, USA).
Cells. Jurkat T cells (TIB-152), HEK293T (CRL-1573), Raji B cells (CCL-86; all
from ATCC), and Platinum-E (Plat-E) retroviral packaging cells (Cell Biolabs, San
Diego, CA, USA) were maintained in RPMI-1640 or Dulbecco’s modiﬁed Eagle
medium (Invitrogen) supplemented with 10% (v/v) fetal bovine serum (FBS;
Invitrogen). Naive CD3+ T cells were puriﬁed from the mouse spleen and lymph
nodes by negative selection using a T cell enrichment column (R&D Systems). To
generate mouse T cell blasts, CD3+ T cells were incubated in 2 µg/mL anti-CD3/
28-coated culture plates with 100 U/mL rIL-2 for 48 h and cultured for a further
5 days with 100 U/mL rIL-2. Mouse splenocytes were dispersed and puriﬁed into
CD4+, CD8+, and CD19+ populations using the EasySep magnetic separation
system (Stemcell Technologies, Vancouver, Canada) or MACS cell separation
(Miltenyi Biotec, Bergisch Gladbach, Germany). The purity of each population was
conﬁrmed as >95% by ﬂow cytometry. To establish B cell blasts, CD19+ cells from
C57BL/6 wild-type mice were activated with LPS (10 μg/mL) for three days in
complete RPMI. Bone marrow was ﬂushed from femur and tibia bones, and bone-
marrow-derived DCs (BMDCs) were grown with the addition of 20 ng/mL gran-
ulocyte macrophage-colony stimulating factor for ﬁve days.
Animals. C57BL/6 wild-type mice and OTII TCR transgenic mice (C57BL/6
background) were purchased from the Jackson Laboratory (Bar Harbor, ME, USA).
Vstm5-knockout mice were generated by Macrogen using CRISPR/Cas9 (Seoul,
Korea). LFA-1-knockout mice were provided by Dr. Minsoo Kim (University of
Rochester, NY, USA). TLR4-knockout mice were provided by Dr. Sang-Myeong
Lee (Chonbuk National University, Iksan, Korea). All mice were housed in speciﬁc
pathogen-free conditions. All experimental methods and protocols were approved
by the Institutional Animal Care and Use Committee of the School of Life Sciences,
Gwangju Institute of Science and Technology (Gwangju, Korea) and performed in
accordance with their approved guidelines.
cDNA constructs. The coding sequences for human or mouse CD3ζ, Vstm5,
TSPAN25, TSG101, and Arrdc1 were cloned by PCR using human or mouse CD3+
T cell cDNA as a template and veriﬁed by sequencing (Macrogen). Vstm5ΔN4
(ΔCNQC) was constructed from wild-type Vstm5 cDNA by mutagenesis.
All obtained PCR products were inserted into the pEGFP_N1, ptdTomato_N1,
or pHJ-1 (CMV promoter) lentiviral vector. PCR was performed with the following
primers (the respective forward and reverse pairs are indicated): human CD3ζ, 5′-T
TGCTAGCGATGAAGTGGAAGGCGCTTTTCACC-3′ and 5′-TTTCTCGAG
GCGAGGGGGCAGGGCCTGCATGTG-3′; mouse CD3ζ, 5′-TTTTTA GATCTC
ATGAAGTGGAAAGTGTCTGTTCTCGCCTGC-3′ and 5′-TTTCGCGGCCGC
GCGAGGGGCCAGGGTCTGCATATGCAGGGC-3′; human Vstm5, 5′-TTGCT
AGCGATG AGGCCTCTGCCCAGCGGGAGGAGGAAG-3′ and 5′-TTTGAGAT
CTGAGCCTCCGGC AGCACACTCAACATCTTCCAGCTCAATCTC-3′; mouse
Vstm5, 5′-TTTTTAGATCTC ATGAGACCACTGCGGTGCGGGGAGAGGAC
C-3′ and 5′-TTTCAGAATTCGGCCTCC GGCAGCACACTCAACTTCTTTCA
TCTCAATCTC-3′; human TSPAN25, 5′-AAGCTA GCGATGGGCATGAGTAG
CTTGAAACTGCTGAAG-3′ and 5′-TTTCAGAATTCGGCC TCCGGCAGCGCC
TCCGGCAGCTAGCCCTATGGTCTGGCTGGTTTTGTCAAT-3′; mouse
TSPAN25, 5′-AAGCTAGCGATGGGCATGAGCAGCCTGAAATTGCTGAAA-3′
and 5′-TTTCAGAATTCGGCCTCCGGCAGCGCCTCCGGCAGCCAGCCCTAA
AGCCTG GCTTGTTTTGTCAAT-3′; mouse TSG101, 5′-GCAAGGAAGACTG
CGGGCCTTAGT GACCTCTACACGGTACCGAAA-3′ and 5′-AAACGGTAC
CGTGTAGAGGTCACTAAG GCCCGCAGTCTTCCTTGC-3′; and mouse
Arrdc1, 5′-AAATCAGATCTCATGGGGAGGGTG CAGCTCTTCGAGATCCG
C-3′ and 5′-AAACAGAATTCGGCTTCCTGGGATCAGGCC AAGGTCTGTA
CC-3′.
Reverse transcription PCR and real-time quantitative (q) PCR. Total RNA was
isolated from cells or homogenized tissues of C57BL/6 mice with TRI reagent
(Molecular Research Center, Cincinnati, OH, USA) and reverse transcribed using
RT-Premix (Intron Biotechnology). PCR was performed with the following primers
(the respective forward and reverse pairs are indicated): mouse Vstm5, 5′- AATG
TCTCCCAAAGCCACAG-3′ and 5′- TAGCGGATCTCAGAC ACACG -3′;
mouse TSPAN25, 5′-GACCATAGCCATCCTGCTCT-3′ and 5′-TGGATGAAGT
CCCATGCCTT-3′; and mouse glyceraldehyde 3-phosphate dehydrogenase
(Gapdh), 5′-GCACAGTCAAGGCCGAGAAT-3′ and 5′-GCCTTCTCCATGGT
GGTGAA-3′. The expression levels of Vstm5 and TSPAN25 were evaluated by
qPCR. Ampliﬁcation was performed in a StepOne real-time PCR system (Applied
Biosystems, Norwalk, CT, USA) for continuous ﬂuorescence detection in a total
volume of 10 μL of cDNA/control and gene-speciﬁc primers using SYBR Premix Ex
Taq (TaKaRa Bio). The mRNA levels of the target genes were normalized relative
to those of Gapdh using the following formula: relative mRNA expression= 2−(ΔCt
of target gene − ΔCt of GAPDH), where Ct is the threshold cycle value. In each sample,
the expression of the analysed gene was normalized to that of Gapdh and described
as the mRNA level relative to Gapdh.
Cell transfection and viral infection. To establish stable cell lines, cDNAs in the
pHJ-1 lentiviral vector were co-transfected with lentiviral-packaging vectors
(pHDM-Hgpm2, pRC/CMV-Rev1b, and pHDM.G) into 293 T cells. The super-
natants were then collected and spin-infected into Jurkat T cells by centrifugation
at 2000 × g for 90 min at 25 °C in the presence of 8 μg/mL polybrene (Sigma-
Aldrich). For retroviral transduction, mouse CD4+ T cells from C57BL/6 or OTII
TCR transgenic mice were incubated in 2 µg/mL anti-CD3/28-coated culture plates
with 100 U/mL rIL-2 for 48 h, and 1 × 106 retroviral packaging cells (platinum-E
cells) were plated overnight in 6-cm2 dishes. Retroviral particles were generated by
transfection with V5G_pMSCV and the pCL-Eco packaging vector using Lipo-
fectamine 2000 (Invitrogen). After 48 h, viral supernatants (2 mL) were harvested,
mixed with 1 × 106 mouse T cells, placed on 20 µg/mL RetroNectin (Clontech,
Mountain View, CA, USA)-coated 12-well plates, and centrifuged at 2000 × g for
90 min at 25 °C with rIL-2 (100 U/mL). The transduced T cells were maintained
with fresh mouse T media with rIL-2 and expanded for ﬁve days. Transient
transfection of mouse T cells and HEK293T cells for gene expression or knock-
down was performed with an Amaxa Nucleofector II and the Mouse T Cell
Nucleofector Kit (Lonza) and Lipofectamine 2000 (Invitrogen), respectively.
Western blot analysis. Cells and isolated TMPs were lysed in ice-cold lysis buffer
(50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1 × complete pro-
tease/phosphatase inhibitor cocktail) for 1 h on ice. Lysates were centrifuged at
16,000 × g for 25 min at 4 °C, and the harvested supernatants were mixed with
sodium dodecyl sulphate (SDS) sample buffer (100 mM Tris-HCl (pH 6.8), 4%
SDS, 20% glycerol, and bromophenol blue) and then heated for 5 min. Proteins
were separated by 10% to 12% SDS polyacrylamide gel electrophoresis (PAGE) and
transferred to nitrocellulose membranes using a Trans-Blot SD semi-dry transfer
cell (Bio-Rad, Hercules, CA, USA). Membranes were then blocked in 5% skim milk
for 1 h, rinsed, and incubated with primary antibodies in Tris-buffered saline
containing 0.1% Tween 20 (TBS-T) and 3% milk overnight. Excess primary anti-
body was removed by washing the membrane four times in TBS-T before incu-
bation with peroxidase-labeled secondary antibody (0.1 μg/mL) for 1.5 h. Bands
were visualized with a WEST-ZOL western blot detection kit and exposed to X-ray
ﬁlm. For determination of Vstm5 localization in the membrane, V5G+ Jurkat
T cells were lysed, and 10 μg of protein of the total lysate was treated with N-
glycosidase F (PNGase F) and endoglycosidase H (EndoH) (both from New
England Biolabs) according to manufacturer instructions and subjected to western
blot. All uncropped blots in the main ﬁgures are shown in Supplementary Figs. 10
through 12.
Subcellular fractionation. Plasma membrane, cytosol, and vesicle fractions were
obtained by differential centrifugation51,52. Cells were washed, mixed with ice-cold
hypotonic buffer (300 mM sucrose, 1 mM EDTA, 20 mM Tris-HCl (pH 7.4), and
complete protease inhibitors), and mechanically lysed with a Dounce homogenizer
(40 strokes). Samples were ﬁrst spun at 4000 × g at 4 °C for 10 min to remove
debris and nuclei, and the supernatants were centrifuged at 17,000 × g for 30 min at
4 °C for the membrane fraction (pellet). Supernatants were recovered and trans-
ferred into clean ultra-microcentrifuge tubes and centrifuged at 100,000× g for
60 min at 4 °C for vesicle (pellet) and cytosol fractions (supernatant). Endoplasmic
reticulum (ER)/mitochondria fractions were obtained as previously described53.
Brieﬂy, 2.5 × ER/mitochondria stabilization buffer (525 mM mannitol, 175 mM
sucrose, 2.5 mM EDTA (pH 7.5), and 12.5 mM Tris-HCl (pH 7.5)) was added to
samples mechanically lysed with a Dounce homogenizer (40 strokes), as described.
After centrifugation at 1300× g for 5 min at 4 °C, the supernatant was recovered
and transferred to clean microcentrifuge tubes. The ﬁrst pellet sample contained
the nuclei, intact cells, and cell debris. Supernatants were centrifuged at 17,000× g
for 15 min at 4 °C for the ER fractions.
Preparation of supported planar lipid bilayers. Bilayers were prepared as
described previously54,55, where lipids (DOPC, Biotin CAP-PE, DOPE-PEG5000,
and DOGS-NTA nickel salt; Avanti Polar Lipids, Birmingham, AL, USA) were
reconstituted in chloroform at 95.5:1:0.5:3 mol%, respectively. The mixture was
then dried under nitrogen and desiccated in a vacuum chamber overnight. The
dried lipid cake was hydrated in PBS, sonicated using a tabletop sonicator for
15 min to generate multilamellar vesicles, and passed through a 50-nm pore
membrane using a mini-extruder (Avanti Polar Lipids). Glass slides (25 × 75 mm;
#1.5; Thermo Fisher Scientiﬁc) were cleaned for 15 min using acetone, 10 N NaOH
for 10 min, and 1M HCl for 10 min and washed thoroughly with MilliQ water.
Slides were then dried and placed in an air plasma cleaner (Harrick Plasma, Ithaca,
NY, USA). To create a bilayer within the ﬂow cell, a 2-μL liposome drop was
deposited on the glass slide between strips of double-sided tape (Ibidi Sticky-Slide
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VI0.4 Luer closed chambers; Ibidi, Martinsried, Germany), after which glass cov-
erslip was placed on top of the glass slide across the double-sided tape, simulta-
neously allowing a single planar bilayer to form on the coverslip surface and
creating a ﬂow chamber. After thorough rinsing with PBS, the chambers were
incubated with ICAM-1 6 × His (250–300 molecules/μm2), followed by avidin
(1 μg/mL), and then thoroughly rinsed again with PBS and incubated with
monobiotinylated MHC I-Ab (20–50 molecules/μm2) for 15 min56. Densities of
molecules on the bilayer were measured as previously described55. Chambers were
rinsed and left in HEPES-buffered saline (HBS) supplemented with 1% human
serum albumin. Lipid bilayers were used for imaging studies on the same day.
TIRFM. To monitor the centripetal movements of TCRβ, V5G, or Arrdc1_GFP,
V5G+ or Arrdc1_GFP+ OTII CD4+ T blasts were stained with TCRβ (H57Fab-
594). The cells were then placed on a planar lipid bilayer presenting OVA323-339-
I-Ab/ICAM-1 and immediately imaged for 10 min to 30 min by TIRFM (IX-81;
Olympus, Tokyo, Japan) equipped with a solid-state laser (488 nm, 20 mW;
Coherent, Santa Clara, CA, USA). In some cases, cells were pretreated with actin
modulators, such as Lat A (237 nM), JAS (100 nM), and CK636 (100 μM), for
30 min before imaging. To examine the generation of V5G+, TCRβ+, or
Arrdc1_GFP+microvillus particles during T cell synapse or kinapse, OTII CD4+ T
blasts as described were imaged for long periods (~2 h) with TIRFM.
Confocal microscopy. Jurkat T, mouse CD3+ T, CD4+ T, OTII CD4+ T, or
HEK293T cells expressing V5G; various tetraspanin proteins including TS25G,
CD3 ζ_ptdTomato, Arrdc1_GFP, or _RFP; or TSG101_GFP in HEPES imaging
buffer were placed on PLL- or anti-CD3/28-coated coverglasses. For LAMP-1
imaging, cells were ﬁxed with 4% paraformaldehyde. Cells were then permeabilised
with 0.1% Triton X-100 in PBS, blocked with 1% BSA/PBS for 1 h, rinsed with PBS,
and incubated with anti-LAMP-1 antibody overnight at 4 °C. Secondary antibodies
were added after washing and incubated in the dark for 1 h at room temperature.
For actin staining, cells were incubated with TRITC-phalloidin in PBS for 30 min at
room temperature. To visualize V5G+ microvilli and actin under live conditions,
V5G+ Jurkat T cells were transfected with LifeA_RFP and then incubated for the
indicated durations (5–30 min) with 1 μg/mL SEE-pulsed Raji B cells. The cells
were then imaged using a 100 × NA 1.40 oil immersion objective and an FV1000
laser scanning confocal microscope (Olympus).
To monitor TMP release under live conditions, DCs (5 × 104) on glass-
bottomed dishes were stained with Cell Tracker Deep Red Dye (1 μM) for 30 min
and washed with warm PBS. V5G+ CD4+ T cells (5 × 105) were then placed on
DCs and incubated in the presence of SEB (5 μg/mL). T cell movement and V5G+
MP release were monitored using a W Plan-Apochromat 40 × /1.0 objective and a
Zeiss LSM 880 confocal laser scanning microscope (Carl Zeiss, Oberkochen,
Germany). V5G+ MP generation was also determined from activated T cells after
incubation with mouse B cells or DCs in the presence or absence of 5 μg/mL
OVA323-339 for 30 min. To quantitate the V5G+ MPs generated during T cell
synapse or kinapse, mouse V5G+ OTII CD4+ T blasts (5 × 105) were incubated on
BMDCs for 1 h, and V5G+ MPs were quantiﬁed as the number within a 50 μm2 ×
50 μm2 area around a single cell using Imaris software (Imaris, Zurich,
Switzerland).
To quantitate TCRβ+ MPs, OTII CD4+ T or CD4+ T blasts (5 × 105) were
stained with TCRβ (H57Fab-594), and the cells were placed on a planar lipid
bilayer presenting OVA323-339-I-Ab with/without ICAM-1 or coverglasses coated
with various antibodies against CD3, LFA1 (CD11a), MHC class I, CD43, and
CD44 for 1 h at 37 °C. At least 20 images for each group were obtained using a
100 × NA 1.40 oil immersion objective and an FV1000 laser scanning confocal
microscope (Olympus).
TMP quantitation. OTII CD4+ T blasts (5 × 105) were placed on anti-CD3 anti-
body lipid bilayers presenting OVA peptide/I-Ab and ICAM-1 or lipid bilayers
presenting ICAM-1, or the cells were treated with anti-CD3 antibody, PMA/
A23187, or ICAM-1 for 1 h at 37 °C. After incubation, the cells were ﬁxed for SEM
analysis. TMPs generated from around a single cell were quantitated as described in
a proceeding subsection.
Image analysis. All imaging data, including the generation of TMPs (by SEM
analysis) and V5G+MPs and TCR+MPs (by confocal analysis), around one single
cell were analysed by ImageJ software (National Institutes of Health, Bethesda, MD,
USA). Six major steps were applied as follows: (1) background subtraction, (2)
sharpening and ﬁnding edges, (3) smoothing and converting to black and white, (4)
closing and ﬁlling holes, (5) denoising and segmenting, and (6) ﬁltering and
measuring. IMARIS software (BitPlane, Belfast, Northern Ireland) was used for
counting and evaluating ﬂuorescent clusters. Cluster movements were tracked
automatically using an algorithm for Brownian movement, and the maximum gap
distance in one frame was set at 5 µm.
Palmitoylation analysis. For [3H]-palmitate labeling, GFP or V5G+ Jurkat T cells
(2 × 107) were stimulated with anti-CD3/28 for 24 h and cultured with 1 mCi [3H]-
palmitate for 4 h. Cells were then washed three times with PBS and lysed in RIPA
buffer (10 mM Tris, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, and 0.1%
deoxycholate (pH 7.35)) in the presence of protease inhibitors. After centrifugation
at 16,000 × g for 25 min at 4 °C, the supernatant was incubated with 10 μg rabbit
anti-GFP antibody for 4 h at 4 °C. ProteinA–Sepharose beads (25 μL; GE Health-
care, Pittsburgh, PA, USA) were added to each sample, and incubation continued
for 2 h at 4 °C. Immunoprecipitates were centrifuged at 16,000 × g for 10 min and,
after removal of the supernatant, washed twice in 0.5 mL ice-cold RIPA buffer.
Samples were separated by SDS-PAGE, and the gels were treated with Enhance
solution (NAMP 100; GE Healthcare) to improve the radioactive signal. Gels were
dried in a Bio-Rad vacuum apparatus (Bio-Rad) and exposed to photographic ﬁlm
for at least 2 weeks at −80 °C.
TMP isolation and puriﬁcation. To isolate TMPs, we developed a puriﬁcation
strategy. Mouse naive CD3+ cells for TMPs or CD4+ cells for 4-TMP T cells were
prepared as described, where 5 × 107 cells were resuspended in serum-free RPMI-
1640 and incubated on anti-CD3-coated plates for 2 h at 37 °C. Cells were then
removed by shaking with cold PBS, and TMPs on culture dishes were dissociated
by the addition of excess anti-CD3 blocking peptides (antibody:peptide molar
ratio= 1:20) in the presence of cold PBS for 30 min. All supernatants were sub-
jected to two successive centrifugations at 2000 × g for 10 min and 2500 × g for
10 min in order to completely eliminate cells and debris and dialyzed in PBS for
24 h at 4 °C. TMPs in PBS were centrifuged for 1 h at 100,000 × g, and pellets were
resuspended with PBS and subjected to western blot, SEM, TEM, and LC-MS/MS
analyses and DC activation. Alternatively, puriﬁed TMPs were further ultra-
centrifuged with a sucrose gradient, as described previously27. Brieﬂy, TMPs
were resuspended in PBS and reloaded onto a sucrose gradient of 12 different
sucrose concentrations from top to bottom (10–90% sucrose) and centrifuged at
100,000 × g for 16 h. Fractions were then carefully collected at 2 mL each from the
bottom of the tube. All fractionated samples were diluted with PBS and subjected to
centrifugation at 100,000 × g for 90 min to pellet the vesicles.
Sample preparation for LC-MS/MS. The same amount of proteins from the total
lysate, membrane, TMPs, and vesicles was subjected to SDS-PAGE on a 12%
polyacrylamide gel and stained with Coomassie Brilliant Blue, after which protein
bands in each lane were excised. After reduction with DTT and alkylation with
iodoacetamide, each band was treated with trypsin to digest the proteins, and
washed with 10 mM ammonium bicarbonate and 50% acetonitrile (ACN), swollen
in digestion buffer containing 50 mM ammonium bicarbonate and 1 μg trypsin,
and incubated at 37 °C for 16 h. Peptides were recovered by two cycles of extraction
with 50 mM ammonium bicarbonate and 100% ACN. The resulting peptide
extracts for each band were pooled, lyophilized, and stored at −20 °C.
NanoLC-electrospray ionization (ESI)-MS/MS for identiﬁcation using Orbi-
trap. Each sample was analysed on an EASY-nLC 1200 nanoLC system equipped
with a trapping column (PepMapTM100; C18 column: 75 µm × 2 cm, 3 µm;
Thermo Fisher Scientiﬁc) and an analytical column (PepMapRSLC; C18 column:
75 µm × 15 cm, 3 µm; Thermo Fisher Scientiﬁc) coupled to an Orbitrap Fusion
Lumos Tribrid mass spectrometer (Thermo Fisher Scientiﬁc) equipped with an
EASY-Spray nanoES-ion source (Thermo Fisher Scientiﬁc). For peptide separation,
the mobile phases comprised 100% water (A) and 80% ACN (B), with each con-
taining 0.1% formic acid. The LC gradient began with 2% mobile phase B, which
was linearly ramped to 6% for 1 min, 10% for 16 min, 50% for 74 min, and 100%
for 1 min, with 100% maintained for 8 min before decreasing to 2% for another
5 min. The column was re-equilibrated with 2% B for 15 min before the next run.
The voltage applied to produce the ES was 2.0 kV. During chromatographic
separation, the Orbitrap Fusion Lumos mass spectrometer was operated in data-
dependent mode, and MS data were acquired using the following parameters: full
scans were acquired in the Orbitrap at a resolution of 120,000 (m/z 400–1600) for
each sample; data-dependent collision-induced dissociation (CID) MS/MS scans
per full scan were acquired during a 3-s cycle time; CID scans were acquired in a
linear trap quadrupole with 35% normalized collision energy; and a 1.2-Da isola-
tion window for MS/MS fragmentation was applied. Previously fragmented ions
were excluded for 12 s.
Protein identiﬁcation. MS/MS spectra were searched against the target-decoy
mouse Refseq database (Uniprot mouse database: 20160306 release) in IP2 (Inte-
grated Proteomics Pipeline). The precursor mass tolerance was conﬁned within
25 p.p.m., with a fragment-mass tolerance of 0.6 Da and an unlimited number of
missed cleavages allowed. Trypsin was selected as the enzyme, carbamidomethy-
lation at cysteine was chosen as a static modiﬁcation, and oxidation at methionine
was chosen as the variable modiﬁcation. The output data ﬁles were ﬁltered and
sorted to construct the protein list using DTASelect, with two or more peptide
assignments required for protein identiﬁcation. Assigned peptides were ﬁltered
with a 5% false discovery rate. The peptide spectral matches (PSMs) of each protein
were normalized by total sample PSMs in order to produce more accurate results
and remove inter-experimental variation. Approximately 300 proteins that were
repeatedly found in each experiment were selected and further analysed for their
differential PSM among different sample groups. Unsupervised hierarchical clus-
tering analysis and PCA57,58 were applied to identify similarity and differences in
the whole proteome among the four groups.
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Measurement of surface proteins on DCs. BMDCs were cultured for an addi-
tional 24 h in media alone or with 100 ng/mL LPS or 4-TMPs derived from acti-
vated CD4+ T cells from wild-type mice. In some cases, to rule out the inﬂuence of
the anti-CD3 antibody on ligation to FcγR on DCs, an FcγR blocking antibody
(clone 2.4G2; BD Pharmingen, San Jose, CA, USA) was pre-incubated with TMPs
for 30 min before treatment. Cells were washed with 1% FBS in PBS and double-
stained with anti-CD11C, anti-CD80, anti-CD86, and anti-CD40 monoclonal
antibodies. Fluorescence intensities were measured in the resuspended cells by ﬂow
cytometry (Beckton Dickinson, Mountain View, CA, USA) and analysed using
FlowJo software (TreeStar, Ashland, OR, USA).
Measurement of calcium inﬂux in DCs. For live imaging of calcium inﬂux in
DCs, BMDCs were stained with 5 μM Fluo-3/AM in FBS-free RPMI-1640 for
30 min at 37 °C, washed, and incubated in complete RPMI-1640 for another
30 min. Cells were resuspended in warmed HBS/human serum albumin (HSA)
buffer and introduced onto the TMP-containing coverglass. To generate TMPs on
lipid bilayers, anti-TCRβ (H57Fab-Alexa594)-stained OTII CD4+ T blasts were
placed on the lipid bilayers presenting pMHC and ICAM-1 for 60 min, and after
removing all of the T cells with cold HBS/HSA, Fluo-3-loaded DCs were intro-
duced onto the TMP-containing coverglass and imaged after 10 min of interaction
with TMPs. To quantify Fluo-3 ﬂuorescence intensity in DCs, cells placed on
“+TMPs” or “−TMPs” were randomly selected and expressed as relative ﬂuores-
cence units (RFU=max−min). Calcium inﬂux was alternatively measured by ﬂow
cytometry. BMDCs (5 × 106) stained with 5 μM Fluo-3/AM were mixed with TMPs
isolated from CD4+ T blasts (5 × 107; ratio, 1:10) and measured for 5 min. In some
inhibition studies, isolated TMPs were pre-incubated with 10 μg of blocking
antibodies, as indicated, for 30 min at room temperature.
Cytokine arrays. Mouse cytokines in the total CD4+ T blasts lysate or 4-TMPs
were measured using the Proteome Proﬁler mouse cytokine XL array kit (R&D
Systems) according to manufacturer instruction. The kit consists of a nitrocellulose
membrane containing 112 different anti-cytokine/chemokine antibodies spotted in
duplicate. Brieﬂy, the membranes were blocked, incubated overnight with each
sample (200 μg), pre-incubated for 1 h with a biotinylated detection-antibody
cocktail, washed, and detected using a horseradish peroxidase-conjugated strep-
tavidin system. The data were presented as heatmaps, with cytokines in TMPs
being 1.5-fold more than those in the CD4+ T blast lysates. The lysates of total
CD4+ T blasts or 4-TMPs (10 μg) were also subjected to ELISA assay (R&D
Systems).
TMP transfer in vitro and in vivo. DCs were cultured on the upper and bottom
compartments of a 0.4-μm pore-sized transwell. OTII CD4+ T cells or V5G+ OTII
CD4+ T cells (1 × 106) were added to upper-well DCs (5 × 105) in the presence or
absence of OVA323-339, and after 2 h, cells were treated with citrate buffer (0.133
M citric acid and 0.066M Na2HPO4 (pH 3.3)) to remove noncovalent protein-
protein interactions between TMPs and the surface of DCs. The treatment was
stopped by adding an excess amount of 5% FBS in PBS. After washing, the cells
were stained with TCRβ for ﬂow cytometry. For DC activation, TMP transfer was
allowed to proceed for 24 h before harvesting. Alternatively, puriﬁed 4-TMPs were
added to culture medium containing DCs in the upper compartment and incu-
bated for 2 h to 24 h before harvesting. For the in vivo assay, OTII TCR transgenic
mice were administered OVA257-264 or OVA323-339 (100 μg; intraperitoneally
(i.p.)) in PBS, respectively. After 48 h, draining lymph nodes were taken and
dissociated.
Electron microscopy. For SEM, cells were ﬁxed with 2.5% glutaraldehyde solution
for 2 h, rinsed with PBS for 5 min, and ﬁxed in osmium tetroxide for 2 h. Samples
were then dehydrated in a graded ethanol series over 30 min and dried in a critical
point dryer. Samples were prepared by sputter coating with 1 nm to 2 nm gold-
palladium and analysed using ﬁeld-emission SEM (Hitachi, Tokyo, Japan). For
TEM, cells were ﬁxed in suspension at 37 °C in a 5% CO2 incubator. Cells (1 mL)
were added to 9 mL of ﬁxative (2.2% glutaraldehyde in 100 mM NaPO4 (pH 7.4))
and ﬁxed for 2 h. Cells were post-ﬁxed in 1% osmium tetroxide, stained en-bloc
with 0.5% uranyl acetate in water, dehydrated in a graded ethanol series, embed-
ded, and thin-sectioned. Sections were stained with 2% uranyl acetate in methanol
for 20 min, followed by lead citrate for 5 min, and then observed using a Tecnai 12
electron microscope (FEI, Hillsboro, OR, USA) at 120 kV under low-dose
conditions.
Statistics. Student’s t test and one-way analysis of variance (corrected for all
pairwise comparisons) were performed using Prism software. A P < 0.05 was
considered statistically signiﬁcant.
Data availability
The data that support the ﬁndings of this study are available from the corresponding
author upon request. Mass spectra are available under MassiVE MSV000082822 and
ProteomeXchange PXD010789.
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